- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/42 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum viral
Patent holdings for IPC class A61K 39/42
Total number of patents in this class: 1931
10-year publication summary
|
79
|
86
|
88
|
105
|
147
|
175
|
144
|
123
|
72
|
13
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Rockefeller University | 584 |
46 |
| Vanderbilt University | 1963 |
41 |
| Duke University | 3170 |
34 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2965 |
34 |
| Humabs Biomed SA | 124 |
33 |
| Regeneron Pharmaceuticals, Inc. | 4573 |
24 |
| California Institute of Technology | 4015 |
23 |
| The Scripps Research Institute | 1346 |
22 |
| Albert Einstein College of Medicine, Inc. | 592 |
21 |
| The Trustees of the University of Pennsylvania | 4406 |
20 |
| The Regents of the University of California | 20502 |
17 |
| International AIDS Vaccine Initiative | 92 |
17 |
| Visterra, Inc. | 125 |
15 |
| Xiamen University | 559 |
15 |
| MedImmune, LLC | 500 |
14 |
| Temasek Life Sciences Laboratory Limited | 138 |
14 |
| The University of Chicago | 1468 |
14 |
| Merck Sharp & Dohme LLC | 3719 |
14 |
| Institute of Microbiology, Chinese Academy of Sciences | 128 |
13 |
| VIR Biotechnology, Inc. | 144 |
13 |
| Other owners | 1487 |